Literature DB >> 15926999

The effects of ponazuril on development of apicomplexans in vitro.

Sheila M Mitchell1, Anne M Zajac, Wendell L Davis, Thomas J Kennedy, David S Lindsay.   

Abstract

We examined the effects of 5 microg/ml ponazuril treatment on developing tachyzoites of Neospora caninum and merozoites of Sarcocystis neurona to better determine the mode of action of this anticoccidial drug. Both parasites develop asexually by endogenesis. Neospora caninum was selected for study because it develops by endodyogeny, which results in two tachyzoites being produced internally, and S. neurona was selected because it develops by endopolygeny which results in many merozoites being produced internally. Ponazuril inhibited development of N. caninum after approximately 48 h post-exposure. Treated tachyzoites of N. caninum developed vacuoles and underwent degeneration. Ponazuril also inhibited development of merozoites of S. neurona. Treated merozoites and maturing schizonts of S. neurona developed vacuoles and underwent degeneration. The ability of S. neurona schizonts to undergo cytokinesis was inhibited. Our results are discussed in relation to previous ultrastructural research on endogenesis of tachyzoites of Toxoplasma gondii undergoing endodyogeny which indicated that ponazuril induced multinucleate stage formation and inhibited cytokinesis. Ponazuril is believed to act on the apicoplast and our study demonstrates that this agent may express its inhibitory effects in different phenotypic manners on different apicomplexan parasites. The enzyme/enzyme systems that are the inhibitory target of ponazuril may be different in these apicomplexans, or the results of inhibition may affect different pathways downstream of its initial site of action in these parasites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15926999     DOI: 10.1111/j.1550-7408.2005.00029.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN: 1066-5234            Impact factor:   3.346


  6 in total

1.  Humoral immune reaction of newborn calves congenitally infected with Neospora caninum and experimentally treated with toltrazuril.

Authors:  Corinne Haerdi; Michael Haessig; Heinz Sager; Gisela Greif; Daniela Staubli; Bruno Gottstein
Journal:  Parasitol Res       Date:  2006-04-21       Impact factor: 2.289

Review 2.  An update on Sarcocystis neurona infections in animals and equine protozoal myeloencephalitis (EPM).

Authors:  J P Dubey; D K Howe; M Furr; W J Saville; A E Marsh; S M Reed; M E Grigg
Journal:  Vet Parasitol       Date:  2015-02-07       Impact factor: 2.738

3.  GC/MS analysis of high-performance liquid chromatography fractions from Sophora flavescens and Torilis japonica extracts and their in vitro anti-neosporal effects on Neospora caninum.

Authors:  Hun-Su Seo; Kyoung Hee Kim; Dae-Yong Kim; Bong-Kyun Park; Nam-Shik Shin; Jae-Hoon Kim; Heejeong Youn
Journal:  J Vet Sci       Date:  2013-06-30       Impact factor: 1.672

4.  Pharmacokinetics of ponazuril after administration of a single oral dose to green turtles (Chelonia mydas).

Authors:  Elliott R Jacobson; Nicole I Stacy; Douglas R Mader; Richie Moretti; Bette Zirkelbach; Olivia Carlile; Courtney D O'Connor; Kaylin J Caperton; Lara K Maxwell
Journal:  Vet Q       Date:  2021-12       Impact factor: 3.320

5.  Pharmacokinetics of orally administered single-dose ponazuril in cats.

Authors:  Catherine Burlison; Sherry Cox; Joseph Smith; Jennifer Stokes; Jacqueline C Whittemore; Becky DeBolt
Journal:  J Vet Pharmacol Ther       Date:  2022-03-20       Impact factor: 1.567

6.  High-throughput screen of drug repurposing library identifies inhibitors of Sarcocystis neurona growth.

Authors:  Gregory D Bowden; Kirkwood M Land; Roberta M O'Connor; Heather M Fritz
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-02-16       Impact factor: 4.077

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.